Effects of Xylitol on Tumor Progression in Syngeneic Mice Cancer Models
Open Access
- 10 January 2025
- journal article
- research article
- Published by MDPI AG in Nutraceuticals
- Vol. 5 (1) , 4
Abstract
This study investigates the effects of xylitol, a natural sugar alcohol, on tumor progression in syngeneic mouse cancer models. Xylitol is known for its dental health benefits, but emerging evidence suggests broader biological roles, including potential anti-cancer properties. We explored xylitol’s impact on two mouse cancer models: 4T1 mammary carcinoma and B16F10 melanoma. Xylitol’s efficacy in inhibiting cancer cell lines and modulating tumor progression was assessed using immunocompetent female mice. The experiments involved intratumoral and peritumoral administration of a 20% xylitol solution in two mouse strains: BALB/c (4T1 mammary carcinoma) and C57BL/6 (B16F10 melanoma). Tumor volume, histopathology, and metabolomic analyses were conducted to gauge xylitol’s influence. The study revealed that xylitol administration initially reduced tumor growth in the B16F10 melanoma model, accompanied by alterations in tumor metabolism. However, similar effects were not observed in the 4T1 mammary carcinoma model, and melanoma tumor growth re-commenced in the melanoma model after stroma deterioration caused xylitol solution leakage. These findings suggest that xylitol may have potential as an adjunct therapy in cancer treatment, specifically in melanoma. The differential response between the two cancer models underscores the complexity of cancer biology and the need for further investigation into xylitol’s mechanisms of action and its role in cancer therapy.Keywords
All Related Versions
Funding Information
- Developmental Therapeutics Core at Northwestern University and the Robert H. Lurie Comprehensive Cancer Center (NCI CA060553)
- Swanson Fund of Northwestern University (NCI CA060553)
This publication has 47 references indexed in Scilit:
- Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeuticsApplied Microbiology and Biotechnology, 2022
- Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapyBiomaterials, 2021
- Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cellsFree Radical Biology and Medicine, 2021
- Xylitol acts as an anticancer monosaccharide to induce selective cancer death via regulation of the glutathione levelChemico-Biological Interactions, 2020
- Novel olive oil phenolic (−)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activitiesInternational Journal of Pharmaceutics, 2019
- Human Gut Microbiota and Gastrointestinal CancerGenomics, Proteomics & Bioinformatics, 2018
- Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly- N -acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinomaEuropean Journal of Pharmaceutical Sciences, 2017
- Understanding the Intersections between Metabolism and Cancer BiologyCell, 2017
- Xylitol induces cell death in lung cancer A549 cells by autophagyBiotechnology Letters, 2015
- Tubers as fallback foods and their impact on Hadza hunter‐gatherersAmerican Journal of Physical Anthropology, 2009